Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.

Journal of virological methods - 1 Aug 2009

Saravanan S, Vidya M, Balakrishnan P, Balakrishanan P, Kumarasamy N, Solomon Sunil S, Solomon S, Kantor Rami, Katzenstein David, Ramratnam Bharat, Mayer Kenneth H

Abstract excerpt

Commercial HIV-1 genotypic resistance assays are very expensive, particularly for use in resource-constrained settings like India. Hence a cost effective in-house assay for drug resistance was validated against the standard ViroSeq HIV-1 Genotyping System 2.0 (Celera Diagnostics, CA, USA). A total of 50 samples were used for this evaluation (21 proficiency panels and 29 clinical isolates). Known resistance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to HIV-1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV/AIDS drug development and treatment

Share to HIV Infections

Share to Microbial Sensitivity Tests

Share to RNA, Viral

Share to Sensitivity and Specificity

Source

Open in PubMed Open full text

Identifiers

PMID: 19490976
DOI: 10.1016/j.jviromet.2009.03.021
PMCID: PMC2923210

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq 2.0 and an in-house method.PMID 19490976Read ↗

Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.Semantic proximity Read ↗

Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.Semantic proximity Read ↗

Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.Semantic proximity Read ↗

[Evaluation of the consistency of three methods for testing HIV-1 genotype drug resistance].Semantic proximity Read ↗

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.Semantic proximity Read ↗

Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.Semantic proximity Read ↗

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.Semantic proximity Read ↗

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited SettingsSemantic proximity Read ↗

Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.Semantic proximity Read ↗

Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.Semantic proximity Read ↗

Performance characteristics of a modified HIV-1 drug resistance genotyping method for use in resource-limited settingsSemantic proximity Read ↗

Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.